About this trial
The Center for Autonomic Medicine in Pediatrics (CAMP), in collaboration with leading CCHS clinicians, scientists, and patient advocacy groups around the world has built the first International CCHS (Congenital Central Hypoventilation Syndrome REDCap (Research Electronic Data Capture) Registry. This registry is an international collaboration to capture CCHS natural history data with CCHS patients and their physicians recruited from around the world. This registry is part of a CCHS natural history study that includes the CCHS Secure Health-hub Advancing Research Efforts (CCHS-SHARE), a natural history data platform shared with the broader CCHS research and patient community to house extensive longitudinal, de-identified data. Inclusion of registry data in CCHS-SHARE is optional.
The purpose of this IRB-approved research study is to gain a better understanding of the natural history of CCHS, including the various clinical manifestations of CCHS with advancing age, and as related to each patient's specific PHOX2B mutation. With a better understanding of CCHS natural history, we will be able to better anticipate healthcare needs and to provide more accurate guidelines to healthcare providers world-wide in caring for patients with CCHS.
The study aims to obtain detailed phenotypic information (information about health and well-being) on patients with CCHS and their families. Participation would require filling out a confidential survey that asks questions regarding phenotype and past medical history. Involvement in the project is completely voluntary and there is no compensation for taking part. However, this project will help us learn more about this disease, with the goal of advancing treatment.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Individuals with PHOX2B mutation-confirmed CCHS.
Disqualifiers
Individuals without PHOX2B mutation-confirmed CCHS.
Trial population
CCHS patients with confirmed PHOX2B mutations
Trial design
Cohort
Prospective
Treatments tested in this trial
Not listed
Trial groups
Trial outcomes
Primary outcomes
Longitudinal phenotype in CCHS
Collection of longitudinal disease history in 400 CCHS patients
Secondary outcomes
Sensitive markers of disease progression by PHOX2B mutation/genotype
Evaluate patient reported outcome measures to determine sensitive markers of disease progression for use in intervention trials
Integration of CCHS Registry and Global Rare Diseases Patient Registry (GRDR)
Develop a patient registry for CCHS for use with the CCHS Secure Health-hub Advancing Research Efforts" (CCHS-SHARE) and the global rare diseases patient registry and data repository (GRDR)
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Debra Weese-Mayer
Lead sponsor
Ann & Robert H Lurie Children's Hospital of Chicago
Sponsor institution
Northwestern University
Collaborator
The Chicago Community Trust
Collaborator